The α-Synuclein seeding assay discriminates between LRRK2 p.Gly2019Ser variant carriers with and without Parkinson's disease.
Background: Reliable biomarkers for Parkinson's disease (PD) pathology detection are essential for research. The alpha-synuclein (aSyn) seed amplification assay (SAA) is a validated biomarker for…